Literature DB >> 12520153

Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma.

Tianshu Zhang1, Naohiko Koide, Yuko Wada, Katsuaki Tsukioka, Kei Takayama, Tetsuya Kono, Hiroto Kitahara, Jun Amano.   

Abstract

Angiogenesis is indispensable to tumor development and proliferation. The aim of this study was to investigate whether the expression of monocyte chemotactic protein-1 (MCP-1) and of thymidine phosphorylase (TP) correlates with the angiogenesis and clinicopathologic features in cardiac myxoma. Paraffin-embedded specimens of 17 resected cardiac myxomas were immunohistochemically stained for MCP-1, CC chemokine receptor-2 (CCR-2), TP, CD31, and CD68. Correlations among MCP-1 expression, TP expression, microvessel count (determined by CD31 staining), macrophage count (determined by CD68 staining), and the clinicopathologic features of the patients were analyzed statistically. Immunohistochemical analysis revealed that MCP-1 and TP were expressed in myxoma cells, as well as in stromal cells such as infiltrating cells, fibroblast-like cells and endothelial cells. CCR-2 was abundantly expressed in stromal infiltrating cells in all myxomas and occasionally in the endothelial cells. In the tumor stroma, the major source of MCP-1, TP and CCR-2 was macrophages, and the sites of positive staining for MCP-1, TP and CCR-2 matched in most of the myxomas. Statistical analysis revealed that the proportions of MCP-1-positive myxoma and stromal cells, and TP-positive myxoma and stromal cells significantly correlated with increased microvessel count. The proportions of MCP-1-positive myxoma and stromal cells significantly correlated with the proportion of TP-positive stromal cells. The mean microvessel count in myxomas with both high tumor and high stromal MCP-1 or TP expression was significantly higher than that in myxomas with low tumor and low stromal MCP-1 or TP expression. Small tumors (< or =55 mm in diameter) exhibited high MCP-1 or TP expression, and the microvessel count in small tumors was significantly higher than in large myxomas. Although the difference was not significant, myxomas with both high tumor and high stromal MCP-1 expression had a higher macrophage count than other myxomas. These results indicate that in cardiac myxoma, MCP-1 and TP may be regarded as important angiogenic signals accompanying growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12520153     DOI: 10.1253/circj.67.54

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Cell differentiation in cardiac myxomas: confocal microscopy and gene expression analysis after laser capture microdissection.

Authors:  Angela Pucci; Claudia Mattioli; Marco Matteucci; Daniele Lorenzini; Francesca Panvini; Simone Pacini; Chiara Ippolito; Michele Celiento; Andrea De Martino; Amelio Dolfi; Beatrice Belgio; Uberto Bortolotti; Fulvio Basolo; Giovanni Bartoloni
Journal:  Heart Vessels       Date:  2018-05-22       Impact factor: 2.037

Review 2.  Molecular basis of cardiac myxomas.

Authors:  Pooja Singhal; Adriana Luk; Vivek Rao; Jagdish Butany
Journal:  Int J Mol Sci       Date:  2014-01-20       Impact factor: 5.923

3.  CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study.

Authors:  Erinaldo Ubirajara Damasceno dos Santos; Géssica Dayane Cordeiro de Lima; Micheline de Lucena Oliveira; Sandra de Andrade Heráclio; Hildson Dornelas Angelo da Silva; Sergio Crovella; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03-15       Impact factor: 2.743

4.  Innate immunity in cardiac myxomas and its pathological and clinical correlations.

Authors:  Anna Di Vito; Gianluca Santise; Chiara Mignogna; Eusebio Chiefari; Gabriella Cardillo; Ivan Presta; Franco Arturi; Natalia Malara; Francesco Brunetti; Annalidia Donato; Domenico Maisano; Stefania Leonetti; Daniele Maselli; Tullio Barni; Giuseppe Donato
Journal:  Innate Immun       Date:  2017-11-16       Impact factor: 2.680

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.